Advertisement

Topics

Evolving Payer Coverage Policies on Genomic Sequencing Tests

20:00 EDT 15 Apr 2018 | JAMA

This Viewpoint discusses a 2018 Centers for Medicare & Medicaid Services national coverage determination on next-generation sequencing tests for patients with advanced cancer and suggests ways to ensure appropriate and equitable access to testing, resource efficiency, and improvement in patient and societal outcomes.

Original Article: Evolving Payer Coverage Policies on Genomic Sequencing Tests

NEXT ARTICLE

More From BioPortfolio on "Evolving Payer Coverage Policies on Genomic Sequencing Tests"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...